1,500 patients to fuel pancreatic cancer research
NCT ID NCT06128343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collects tumor tissue and medical information from 1,500 people with pancreatic cancer. The goal is to build a large biobank that scientists can use to better understand the disease and develop new treatments. Participants undergo standard diagnostic procedures, and no experimental therapy is offered.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Béthune hospital center
NOT_YET_RECRUITINGBéthune, 62408, France
-
Haut-Lévêque Hospital
NOT_YET_RECRUITINGBordeaux, 33604, France
-
Huriez Hospital
NOT_YET_RECRUITINGLille, 59037, France
-
Jean Mermoz private hosptila
NOT_YET_RECRUITINGLyon, 69008, France
-
PAU hospital
NOT_YET_RECRUITINGPau, 6400, France
-
Rangueil hospital
RECRUITINGToulouse, 31059, France
-
Regional Cancer Center From Montpellier
NOT_YET_RECRUITINGMontpellier, 34298, France
-
Saint Eloi Hospital
NOT_YET_RECRUITINGMontpellier, 34295, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a pill rouse the immune system against pancreatic cancer?
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new immune drug outsmart Hard-to-Treat tumors?
- A sound wave that could expose hidden pancreatic cancer?